A detailed history of Virtus Fund Advisers, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 3,456 shares of CDNA stock, worth $78,243. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,456
Previous 3,243 6.57%
Holding current value
$78,243
Previous $34,000 55.88%
% of portfolio
0.21%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $1,610 - $3,439
213 Added 6.57%
3,456 $53,000
Q4 2023

Feb 15, 2024

BUY
$4.9 - $12.86 $15,890 - $41,704
3,243 New
3,243 $38,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.21B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.